Synovics Pharmaceuticals Announces Continued Growth of Customer Rel...(e any forward-looking statements whether...)
Home
Biology
Medicine
Technology
Products
News
Definition
Dictionary
Movies
Links
Tags
Search
RSS
Navigation Links
Biology News
Medicine News
Biology Products
Medicine Products
Biology Definition
Medicine Definition
Biology Technology
Medicine Technology
Biology Dictionary
Medicine Dictionary
HOME
>>
BIOLOGY
>>
TECHNOLOGY
Synovics Pharmaceuticals Announces Continued Growth of Customer Relationships
e any forward-looking statements whether as a result of newinformation future events or otherwise except to the extent requiredunder applicable law.
http://www.bio-medicine.org/inc/biomed/biology-technology.asp
http://feeds.bio-medicine.org/latest-biology-technology
Date:6/18/2008
e any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required under applicable law.
'/>"/>
SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008
PR Newswire.
All rights reserved
0
GOOD
Page:
1
2
3
4
5
Related biology technology :
1
.
Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2
.
China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3
.
Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4
.
XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5
.
Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6
.
Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7
.
Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8
.
Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9
.
NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10
.
Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11
.
Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*
Name:
*
Comment:
*
Email:
Breaking Biology Technology:
Endologix Appoints Dan Lemaitre to its Board of Directors 2
Successful Stem Cell Therapy for Treatment of Eye Disease 2
Successful Stem Cell Therapy for Treatment of Eye Disease 3
Successful Stem Cell Therapy for Treatment of Eye Disease 4
China Biologic Products to Ring NASDAQ Opening Bell 2
China Biologic Products to Ring NASDAQ Opening Bell 3
Biomatrica Launches SampleWare 3.1 2
Biomatrica Launches SampleWare 3.1 3
[
0
] Endologix Appoints Dan Lemaitre to its Board of Directors
[
0
] Successful Stem Cell Therapy for Treatment of Eye Disease
[
0
] China Biologic Products to Ring NASDAQ Opening Bell
[
0
] Biomatrica Launches SampleWare 3.1
Other Biology Technology:
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets 2
Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference 2
Beckman Coulter to Present at the JPMorgan Healthcare Conference
Perrigo Announces FDA Approval for Over-The-Counter Cetirizine Hydrochloride Tablets
Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
Breaking Biology News(10 mins):
Bacteria provide new insights into human decision making 2
Bacteria provide new insights into human decision making 3
Bacteria provide new insights into human decision making 4
Bacteria provide new insights into human decision making 5
Case Western Reserve University grants option to startup Thermalin Diabetes Inc. 2
Scientists identify natural anti-cancer defenses 2
FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 60789 1
FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 60789 2
FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 60789 3
FreedomVOICE Proposes Telecommuting to Tackle the H1N1 Virus 60789 4
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 1
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 2
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 3
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 4
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 5
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 6
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 7
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 8
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 9
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 10
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 11
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 12
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 13
Volcano Reports 22 Percent Increase in Third Quarter Revenues 60786 14
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 1
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 2
DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 14743 3
[
0
] Bacteria provide new insights into human decision making
[
0
] Case Western Reserve University grants option to startup Thermalin Diabetes Inc.
[
0
] Scientists identify natural anti-cancer defenses
Other Biology News:
Protein synthesis can be controlled by light, opening way for new scientific, medical applications 2
Protein synthesis can be controlled by light, opening way for new scientific, medical applications 3
Genome study of beneficial microbe may help boost plant health 2
Critical step traced in anthrax infection 2
Protein synthesis can be controlled by light, opening way for new scientific, medical applications
Genome study of beneficial microbe may help boost plant health
Critical step traced in anthrax infection
Biology Products:
GIBCO Sf-900 II SFM (1X) liquid from Invitrogen
PureLink 96 PCR Purification Kit from Invitrogen
Zero Blunt TOPO PCR Cloning Kit with One Shot TOP10 Chemically Competent E. coli from Invitrogen
Beacon 2000 Lamps from Invitrogen
Biology Navigation
AIDS/HIV
Bioinformatics
Biotechnology
Biochemistry
Cancer
Cell Biology
Developmental Biology
Ecology
Environment
Evolution
Food Technology
Gene
Genetics
Genomics
Health/Medicine
Immunology
Microarray
Microbiology
Molecular
Marine Biology
Nanobiotechnology
Neurobiology
Plant Sciences
Stem Cell
Systems Biology
Virus
Women Health
Medical Navigation
Abortion
Aches
ADHD
Addiction
Alcohol
Allergy
Alternative Medicine
Alzheimer's Dementia
Anxiety/Stress
Arthritis
Autism
Bacteria
Blood
Bird Flu/Avian Flu
Bones
Breast Cancer
Cancer
Cardiovascular
Cervical Cancer
Chikungunya
Cholesterol
Clinical Trials
Colorectal Cancer
Conferences
Crohn's
Cystic Fibrosis
Dengue
Dentistry
Depression
Diabetes
Drug
Eating Disorders
Education
Epilepsy
Erectile Dysfunction
Eye Health/Blindness
Fertility
Flu/Cold
GastroIntestinal
Genetics
Gout
Headache/Migraine
Hearing/Deafness
HIV/AIDS
Huntington's Disease
Hypertension
Immune System/Vaccines
Insurance
Infectious Diseases
Irritable-Bowel Syndrome
Internet
Leukemia
Lifestyle
Liver Disease/Hepatitis
Lung Cancer
Lupus
Mad Cow Disease
Medical Devices
Medical Students/Training
Medicare/Medicaid
Medico
Men's health
Mental Health
MRI/Ultrasound
MRSA/Drug Resistance
Multiple Sclerosis
Muscular Dystrophy
Neurology
Nursing
Nutrition/Diet
Obesity/Weight Loss
Pain/Anesthetics
Parkinson's Disease
Pediatrics/Children's Health
Pharma/Biotech Industry
Pharmacy/Pharmacists
Pregnancy
Premature
Prostate
Psychology/Psychiatry
Rehabilitation
Respiratory/Asthma
SARS
Schizophrenia
Seniors/Aging
Sexual Health
Sleep/Sleep Disorders
Smoking
Statins
Stem Cell Research
Stroke
Surgery
Transplants/Organ Donations
Viruses
Water - Air Quality
Women's Health